Skip to main content

MoneyWorks4Me

Dishman Carbogen Amcis informs about press release

28 Oct 2021 Evaluate
Dishman Carbogen Amcis has informed that the Company's wholly owned subsidiary namely CARBOGEN AMCIS SAS, France, announces the release of a new batch for clinical trials of AGuIX Drug Product for NH TherAguix, a clinical stage company developing innovative nano medicine for the treatment of cancer. In this regard, it enclosed Press Release.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1905.90
Dr. Reddys Labs. 1400.15
Cipla 1406.70
Lupin 2018.20
Zydus Lifesciences 1207.00
View more..